You can Subscribe to our RSS FEED:
which delivers brain tumor news and additions
to the website via RSS.
Click HERE for details on RSS.
Displaying items 1 to 25 of about 5157
The UCLA Brain Tumor Center will host part two of its Brain Tumor Virtual Conference on Friday, March 12th
The addition of chloroquine and bevacizumab to standard radiochemotherapy for recurrent glioblastoma multiforme
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma
Setting international standards in analyzing patient-reported outcomes and QOL endpoints
Are you Considering Optune Therapy for GBM?
New zebrafish model could help advance glioblastoma multiforme research
Brain tumor study reveals surprising gene deletion and method to overcome drug resistance
The effects of releasing early results from ongoing clinical trials
Sydney researchers identify/advance potential revolutionary new drug treatment for fatal childhood cancer
New combination treatment approach improves overall survival in mice with glioblastoma
GammaTile webinar posted to our video library!
Amazon Smile Fundraiser! Action Required!
Musella Foundation awards two brain tumor research grants!
First Glioblastoma Patient Dosed in Phase 2 Trial Testing PVSRIPO Plus Keytruda
Very Low Mutation Burden Is a Feature of Inflamed Recurrent Glioblastomas Responsive to Cancer Immunotherapy
Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial
Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research
Learn More About GammaTile® Therapy, Surgically Targeted Radiation Therapy For Brain Tumors, At Patient Education Event On Thursday, February 4
NEW MAGNETIC RESONANCE IMAGING (MRI) TECHNIQUE UNCOVERS PATHOPHYSIOLOGICAL PROCESS TO HELP EARLY DETECTION OF RECURRENT GLIOBLASTOMA
Targepeutics Receives Orphan Drug Designation for Lead Drug Targeting Malignant Glioma
Outcomes and Patterns of Care in Elderly Glioblastoma Multiforme Patients: A Population-Based Study of the National Cancer Database
The Role of Temozolomide in Patients With Newly Diagnosed Wild-Type IDH, Unmethylated MGMTp Glioblastoma During the COVID-19 Pandemic
Brain Cancer Advocate Al Musella Joins Childhood Cancer Foundation Board of Directors
Body mass index as an independent prognostic factor in glioblastoma
Brain Tumor News Blast
Enter your email address to subscribe!
Copyright © 1993 - 2021 Musella Foundation- All Rights Reserved.
Website by LcsProductionDesign.com